Medication classes used in diabetes and cardiovascular diseases (lipid modifying agents, agents acting on the renin-angiotensin system, beta blocking agents and calcium channel blockers) were frequently claimed across all groups, with lipid modifying agents being the most frequent category. This evidence concerns the gene REN and cardiovascular disorder.